• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

非酒精性脂肪性肝病:肥胖和代谢综合征的肝脏后果。

Non-alcoholic fatty liver disease: the hepatic consequence of obesity and the metabolic syndrome.

机构信息

Nutritional Sciences Division, Faculty of Health and Medical Sciences, University of Surrey, Guildford, Surrey GU2 7XH, UK.

出版信息

Proc Nutr Soc. 2010 May;69(2):211-20. doi: 10.1017/S0029665110000030. Epub 2010 Feb 17.

DOI:10.1017/S0029665110000030
PMID:20158939
Abstract

Non-alcoholic fatty liver disease (NAFLD) is now the most common liver disease in both adults and children worldwide. As a disease spectrum, NAFLD may progress from simple steatosis to steatohepatitis, advanced fibrosis and cirrhosis. An estimated 20-35% of the general population has steatosis, 10% of whom will develop the more progressive non-alcoholic steatohepatitis associated with markedly increased risk of cardiovascular- and liver-related mortality. Development of NAFLD is strongly linked to components of the metabolic syndrome including obesity, insulin resistance, dyslipidaemia and type 2 diabetes. The recognition that NAFLD is an independent risk factor for CVD is a major public health concern. There is a great need for a sensitive non-invasive test for the early detection and assessment of the stage of NAFLD that could also be used to monitor response to treatment. The cellular and molecular aetiology of NAFLD is multi-factorial; genetic polymorphisms influencing NAFLD have been identified and nutrition is a modifiable environmental factor influencing NAFLD progression. Weight loss through diet and exercise is the primary recommendation in the clinical management of NAFLD. The application of systems biology to the identification of NAFLD biomarkers and factors involved in NAFLD progression is an area of promising research.

摘要

非酒精性脂肪性肝病(NAFLD)现已成为全世界成年人和儿童最常见的肝脏疾病。作为一种疾病谱,NAFLD 可能从单纯性脂肪变性进展为脂肪性肝炎、晚期纤维化和肝硬化。据估计,一般人群中有 20-35%患有脂肪变性,其中 10%将发展为更具进展性的非酒精性脂肪性肝炎,其与心血管和肝脏相关死亡率的显著增加相关。NAFLD 的发生与代谢综合征的成分密切相关,包括肥胖、胰岛素抵抗、血脂异常和 2 型糖尿病。认识到 NAFLD 是 CVD 的一个独立危险因素是一个主要的公共卫生关注点。非常需要一种敏感的非侵入性检测方法来早期发现和评估 NAFLD 的阶段,也可以用于监测治疗反应。NAFLD 的细胞和分子病因是多因素的;已经确定了影响 NAFLD 的遗传多态性,营养是影响 NAFLD 进展的可改变环境因素。通过饮食和运动减肥是非酒精性脂肪性肝病临床管理的主要建议。将系统生物学应用于 NAFLD 生物标志物和 NAFLD 进展相关因素的鉴定是一个很有前途的研究领域。

相似文献

1
Non-alcoholic fatty liver disease: the hepatic consequence of obesity and the metabolic syndrome.非酒精性脂肪性肝病:肥胖和代谢综合征的肝脏后果。
Proc Nutr Soc. 2010 May;69(2):211-20. doi: 10.1017/S0029665110000030. Epub 2010 Feb 17.
2
Non-alcoholic fatty liver disease.非酒精性脂肪性肝病。
J Diabetes. 2012 Sep;4(3):266-80. doi: 10.1111/j.1753-0407.2012.00204.x.
3
Nonalcoholic fatty liver disease: hepatic manifestation of obesity and the metabolic syndrome.非酒精性脂肪性肝病:肥胖和代谢综合征的肝脏表现。
Postgrad Med. 2008 Jul 31;120(2):E01-7. doi: 10.3810/pgm.2008.07.1800.
4
Role of diet and nutritional management in non-alcoholic fatty liver disease.饮食和营养管理在非酒精性脂肪性肝病中的作用。
J Gastroenterol Hepatol. 2013 Dec;28 Suppl 4:81-7. doi: 10.1111/jgh.12244.
5
What are the risk factors and settings for non-alcoholic fatty liver disease in Asia-Pacific?亚太地区非酒精性脂肪性肝病的风险因素及相关情况有哪些?
J Gastroenterol Hepatol. 2007 Jun;22(6):794-800. doi: 10.1111/j.1440-1746.2007.04952.x. Epub 2007 May 13.
6
Weight loss: cornerstone in the treatment of non-alcoholic fatty liver disease.体重减轻:非酒精性脂肪性肝病治疗的基石。
Minerva Gastroenterol Dietol. 2010 Jun;56(2):159-67.
7
[Non-alcoholic fatty liver disease--new view].[非酒精性脂肪性肝病——新视角]
Pol Merkur Lekarski. 2008 Jun;24(144):568-71.
8
[Treatment of non-alcoholic fatty liver disease].[非酒精性脂肪性肝病的治疗]
Ned Tijdschr Geneeskd. 2011;155:A3181.
9
[Non-alcoholic fatty liver].[非酒精性脂肪肝]
Rev Gastroenterol Peru. 2003 Jan-Mar;23(1):49-57.
10
Obesity and fatty liver are 'grease' for the machinery of hepatic fibrosis.肥胖和脂肪肝是肝纤维化机制的“润滑剂”。
Dig Dis. 2011;29(4):377-83. doi: 10.1159/000329800. Epub 2011 Aug 30.

引用本文的文献

1
A review on the effect of green tea extract against obesity.绿茶提取物对肥胖影响的综述
Food Sci Biotechnol. 2024 Dec 16;34(8):1661-1678. doi: 10.1007/s10068-024-01778-8. eCollection 2025 Apr.
2
Association of anthropometric and obesity indices with abnormal blood lipid levels in young and middle-aged adults.中青年成人人体测量学指标和肥胖指数与血脂异常水平的关联
Heliyon. 2024 Dec 26;11(1):e41310. doi: 10.1016/j.heliyon.2024.e41310. eCollection 2025 Jan 15.
3
The role of gut microbiota augmentation in managing non-alcoholic fatty liver disease: an in-depth umbrella review of meta-analyses with grade assessment.
肠道微生物群增强在非酒精性脂肪性肝病管理中的作用:一项带有分级评估的荟萃分析的深入系统性综述
Ann Med Surg (Lond). 2024 Jun 20;86(8):4714-4731. doi: 10.1097/MS9.0000000000002276. eCollection 2024 Aug.
4
Non-Alcoholic Fatty Liver Disease Induced by Feeding Medium-Chain Fatty Acids Upregulates Cholesterol and Lipid Homeostatic Genes in Skeletal Muscle of Neonatal Pigs.喂食中链脂肪酸诱导的非酒精性脂肪性肝病上调新生仔猪骨骼肌中的胆固醇和脂质稳态基因。
Metabolites. 2024 Jul 11;14(7):384. doi: 10.3390/metabo14070384.
5
Hepatoprotective Mechanisms Induced by Spinach Methanolic Extract in Rats with Hyperglycemia-An Immunohistochemical Analysis.菠菜甲醇提取物对高血糖大鼠的肝保护机制——免疫组织化学分析
Antioxidants (Basel). 2023 Nov 17;12(11):2013. doi: 10.3390/antiox12112013.
6
Non-alcoholic Fatty Liver in Children and Adolescents in Saudi Arabia.沙特阿拉伯儿童和青少年中的非酒精性脂肪性肝病
Cureus. 2023 Oct 2;15(10):e46380. doi: 10.7759/cureus.46380. eCollection 2023 Oct.
7
Unraveling the mechanisms of trans-cinnamic acid in ameliorating non-alcoholic fatty liver disease.解析反式肉桂酸改善非酒精性脂肪性肝病的机制
Am J Transl Res. 2023 Sep 15;15(9):5747-5756. eCollection 2023.
8
Appropriate sleep duration modifying the association of insulin resistance and hepatic steatosis is varied in different status of metabolic disturbances among adults from the United States, NHANES 2017-March 2020.在美国国家健康与营养检查调查(NHANES)2017年至2020年3月期间,不同代谢紊乱状态的成年人中,适当的睡眠时间对胰岛素抵抗和肝脂肪变性关联的影响有所不同。
Prev Med Rep. 2023 Sep 9;36:102406. doi: 10.1016/j.pmedr.2023.102406. eCollection 2023 Dec.
9
Effects of gut microbial therapy on lipid profile in individuals with non-alcoholic fatty liver disease: an umbrella meta-analysis study.肠道微生物治疗对非酒精性脂肪性肝病患者血脂谱的影响:伞式荟萃分析研究。
Syst Rev. 2023 Aug 21;12(1):144. doi: 10.1186/s13643-023-02299-x.
10
Protective role of thymoquinone in hyperlipidemia-induced liver injury in LDL-Rmice.胸腺醌在 LDL-R 小鼠高脂血症诱导的肝损伤中的保护作用。
BMC Gastroenterol. 2023 Aug 11;23(1):276. doi: 10.1186/s12876-023-02895-0.